Cell Search Circulating Tumour Cell Test
Exclusively performed by SAM Clinical Laboratory in Southeast Asia, the Cellsearch® (CTC) Test is the only FDA-approved test for enumerating CTCs. It is an actionable test that assists healthcare professionals in the assessment of patients with metastatic breast, prostate or colorectal cancer.
Benefits
- FDA-approved
- Early assessment of patient prognosis
Recommended For
Patients who wish to be tested for the possibility of metastatic breast, prostate or colorectal cancer.
Process
Specimen collection kits are to be obtained from a local representative with samples administered accordingly.
Results will be released within 2 to 5 business days upon receipt of completed specimen kits.
Downloads
- FDA-approved
- Early assessment of patient prognosis
Patients who wish to be tested for the possibility of metastatic breast, prostate or colorectal cancer.
Specimen collection kits are to be obtained from a local representative with samples administered accordingly.
Results will be released within 2 to 5 business days upon receipt of completed specimen kits.
